Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AorTech blames Ultracor for disappointing results:

This article was originally published in Clinica

Executive Summary

AorTech International, a UK company which produces the Ultracor mechanical heart valve, says that a downturn in its annual sales, from last year's £2.2 million ($3.6 million) to this year's £1.8 million was due primarily to disappointing sales of the valves. However, losses also diminished. The company is predicting that the results of a major study in Germany on the valve's performance should have a "significant positive impact on sales during ensuing years". AorTech raised $3 million in May through a share issue to new and existing shareholders (see Clinica No 809, p 11).





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts